Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ECCO Essential Requirements for Quality Cancer Care: Prostate cancer.
Brausi M, Hoskin P, Andritsch E, Banks I, Beishon M, Boyle H, Colecchia M, Delgado-Bolton R, Höckel M, Leonard K, Lövey J, Maroto P, Mastris K, Medeiros R, Naredi P, Oyen R, de Reijke T, Selby P, Saarto T, Valdagni R, Costa A, Poortmans P. Brausi M, et al. Crit Rev Oncol Hematol. 2020 Apr;148:102861. doi: 10.1016/j.critrevonc.2019.102861. Epub 2020 Jan 7. Crit Rev Oncol Hematol. 2020. PMID: 32151466 Review.
Focal therapy in prostate cancer-report from a consensus panel.
de la Rosette J, Ahmed H, Barentsz J, Johansen TB, Brausi M, Emberton M, Frauscher F, Greene D, Harisinghani M, Haustermans K, Heidenreich A, Kovacs G, Mason M, Montironi R, Mouraviev V, de Reijke T, Taneja S, Thuroff S, Tombal B, Trachtenberg J, Wijkstra H, Polascik T. de la Rosette J, et al. Among authors: brausi m. J Endourol. 2010 May;24(5):775-80. doi: 10.1089/end.2009.0596. J Endourol. 2010. PMID: 20477543
Role of multiparametric magnetic resonance imaging (MRI) in focal therapy for prostate cancer: a Delphi consensus project.
Muller BG, van den Bos W, Brausi M, Cornud F, Gontero P, Kirkham A, Pinto PA, Polascik TJ, Rastinehad AR, de Reijke TM, de la Rosette JJ, Ukimura O, Villers A, Walz J, Wijkstra H, Marberger M. Muller BG, et al. Among authors: brausi m. BJU Int. 2014 Nov;114(5):698-707. doi: 10.1111/bju.12548. Epub 2014 Aug 16. BJU Int. 2014. PMID: 24180365
Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus project.
Muller BG, van den Bos W, Brausi M, Fütterer JJ, Ghai S, Pinto PA, Popeneciu IV, de Reijke TM, Robertson C, de la Rosette JJ, Scionti S, Turkbey B, Wijkstra H, Ukimura O, Polascik TJ. Muller BG, et al. Among authors: brausi m. World J Urol. 2015 Oct;33(10):1503-9. doi: 10.1007/s00345-014-1475-2. Epub 2015 Jan 6. World J Urol. 2015. PMID: 25559111 Free PMC article. Review.
Prostate Cancer Unit Initiative in Europe: A position paper by the European School of Oncology.
Valdagni R, Van Poppel H, Aitchison M, Albers P, Berthold D, Bossi A, Brausi M, Denis L, Drudge-Coates L, De Santis M, Feick G, Harrison C, Haustermans K, Hollywood D, Hoyer M, Hummel H, Mason M, Mirone V, Müller SC, Parker C, Saghatchian M, Sternberg CN, Tombal B, van Muilekom E, Watson M, Wesselmann S, Wiegel T, Magnani T, Costa A. Valdagni R, et al. Among authors: brausi m. Crit Rev Oncol Hematol. 2015 Aug;95(2):133-43. doi: 10.1016/j.critrevonc.2015.05.014. Epub 2015 Jun 5. Crit Rev Oncol Hematol. 2015. PMID: 26092320 Review.
Increasing age is not associated with toxicity leading to discontinuation of treatment in patients with urothelial non-muscle-invasive bladder cancer randomised to receive 3 years of maintenance bacille Calmette-Guérin: results from European Organisation for Research and Treatment of Cancer Genito-Urinary Group study 30911.
Oddens JR, Sylvester RJ, Brausi MA, Kirkels WJ, van de Beek C, van Andel G, de Reijke TM, Prescott S, Alfred Witjes J, Oosterlinck W. Oddens JR, et al. Among authors: brausi ma. BJU Int. 2016 Sep;118(3):423-8. doi: 10.1111/bju.13474. Epub 2016 Apr 2. BJU Int. 2016. PMID: 26945890 Clinical Trial.
Multidisciplinary teams for the proper management of patients with genitourinary tumors: When topics set scientific societies' agenda.
Magnani T, Bracarda S, D'Angelillo RM, Artibani W, Barni S, Beretta G, Brausi M, Caffo O, Corvò R, Gallucci M, Gunelli R, Mirone V, Novara G, Pinto C, Russi E, Santoni R, Tomirotti M, Volpe A, Conti G, Valdagni R. Magnani T, et al. Among authors: brausi m. Tumori. 2019 Apr;105(2):161-167. doi: 10.1177/0300891618784789. Epub 2018 Jul 5. Tumori. 2019. PMID: 29974825
The European Prostate Cancer Centres of Excellence: A Novel Proposal from the European Association of Urology Prostate Cancer Centre Consensus Meeting.
Wirth M, Fossati N, Albers P, Bangma C, Brausi M, Comperat E, Faithfull S, Gillessen S, Jereczek-Fossa BA, Mastris K, Mottet N, Müller SC, Pieters B, Ribal MJ, Sangar V, Schoots IG, Smelov V, Travado L, Valdagni R, Wesselmann S, Wiegel T, van Poppel H. Wirth M, et al. Among authors: brausi m. Eur Urol. 2019 Aug;76(2):179-186. doi: 10.1016/j.eururo.2019.01.033. Epub 2019 Feb 22. Eur Urol. 2019. PMID: 30799188
[No title available]
[No authors listed] [No authors listed] PMID: 34701053
Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer--Genito-Urinary Group Phase III Trial (30906).
de Reijke TM, Kurth KH, Sylvester RJ, Hall RR, Brausi M, van de Beek K, Landsoght KE, Carpentier P; European Organization for the Research and Treatment of Cancer-Genito-Urinary Group. de Reijke TM, et al. Among authors: brausi m. J Urol. 2005 Feb;173(2):405-9. doi: 10.1097/01.ju.0000150425.09317.67. J Urol. 2005. PMID: 15643181 Clinical Trial.
135 results